New way to measure treatment success in primary mitochondrial disease
Goal attainment scaling may be a useful tool in clinical trials for primary mitochondrial diseases like TK2d.
Goal attainment scaling may be a useful tool in clinical trials for primary mitochondrial diseases like TK2d.
As progress is made in treating primary mitochondrial disorders such as TK2d, doctors may need to rethink how they talk about prognosis.
The earliest symptoms of TK2d usually involve muscles and movement.